Cargando…
Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers
Schistosoma haematobium is the leading cause of urogenital schistosomiasis and it is recognised as a class 1 carcinogen due to the robust association of infection with bladder cancer. In schistosomes, tetraspanins (TSPs) are abundantly present in different parasite proteomes and could be potential d...
Autores principales: | Mekonnen, Gebeyaw G., Tedla, Bemnet A., Pearson, Mark S., Becker, Luke, Field, Matt, Amoah, Abena S., van Dam, Govert, Corstjens, Paul L. A. M., Mduluza, Takafira, Mutapi, Francisca, Loukas, Alex, Sotillo, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812969/ https://www.ncbi.nlm.nih.gov/pubmed/35073344 http://dx.doi.org/10.1371/journal.pntd.0010151 |
Ejemplares similares
-
In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
por: Sotillo, Javier, et al.
Publicado: (2019) -
Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis
por: Mekonnen, Gebeyaw G., et al.
Publicado: (2020) -
Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
por: Nausch, Norman, et al.
Publicado: (2011) -
Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
por: Reilly, Liam, et al.
Publicado: (2012) -
Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium
por: Mitchell, Kate M., et al.
Publicado: (2014)